Erdafitinib Powder – Pharmaceutical Grade Research Material

Erdafitinib powder is a specialized pharmaceutical compound used in oncology research and drug development. It is also known as erdafitinib API or erdafitinib active pharmaceutical ingredient. The compound belongs to the FGFR inhibitor class of targeted kinase inhibitors.

Erdafitinib has attracted significant interest in pharmaceutical research because it targets fibroblast growth factor receptors. In particular, its activity includes FGFR3 signaling. This pathway plays an important role in certain urothelial cancers.

For qualified pharmaceutical and research organizations, erdafitinib powder can serve as a valuable material for analytical studies and formulation development. Therefore, buyers should review applicable regulatory requirements before handling or importing this compound.

Erdafitinib Powder Specifications

Erdafitinib has the chemical formula C25H30N6O2. Its molecular weight is 446.56 g/mol. Regulatory documentation describes erdafitinib as a yellow crystalline powder.

The compound has limited solubility in aqueous media. However, it shows different solubility characteristics in selected organic solvents. Its physicochemical profile makes appropriate analytical testing important during pharmaceutical development.

The European Medicines Agency assessment report identifies erdafitinib as a non-hygroscopic crystalline yellow powder. It also reports that the molecule is non-chiral and that polymorphism has not been observed.

Key Chemical Information

The following specifications provide useful reference information for pharmaceutical research and analytical applications.

Specification	Details
Product name	Erdafitinib Powder
Active ingredient	Erdafitinib
CAS-related identity	Verify against current supplier CoA
Molecular formula	C25H30N6O2
Molecular weight	446.56 g/mol
Appearance	Yellow crystalline powder
Physical form	Powder
Compound class	FGFR tyrosine kinase inhibitor
Target pathway	FGFR signaling
Water solubility	Limited
Chirality	Non-chiral
Polymorphism	Not observed in EMA assessment
Intended market	Qualified pharmaceutical and research users

Always confirm batch-specific specifications through the applicable certificate of analysis. Product specifications can vary according to manufacturing standards, analytical methods, and applicable regulatory requirements.

Erdafitinib API for Pharmaceutical Research

Erdafitinib is an important compound for targeted oncology research. It inhibits FGFR activity, including signaling associated with susceptible FGFR3 alterations. Consequently, researchers can investigate FGFR-driven biological pathways using suitable experimental models.

The EMA describes erdafitinib as an FGFR tyrosine kinase inhibitor. The approved medicine Balversa contains erdafitinib as its active substance.

Moreover, the European regulatory assessment provides detailed information about the active substance. This includes its chemical structure, solid-state characteristics, particle size control, and physicochemical properties.

Applications in Research and Development

Erdafitinib powder may be relevant to qualified organizations involved in:

• Pharmaceutical research
• Analytical method development
• API characterization
• Drug formulation research
• FGFR pathway studies
• Oncology research programs
• Reference-standard development
• Preclinical pharmaceutical investigations

These applications require appropriate laboratory facilities and trained personnel. Furthermore, organizations should follow applicable safety procedures and local regulations.

Why Choose Erdafitinib Powder?

A reliable supply of pharmaceutical research materials supports consistent development programs. Therefore, product identity, documentation, packaging, and batch traceability are important purchasing considerations.

Erdafitinib powder offers a defined chemical identity and well-characterized molecular structure. Its molecular formula and molecular weight are documented by regulatory authorities.

In addition, the material can support organizations working on analytical and pharmaceutical development projects. Buyers should request current documentation before placing an order.

Quality and Documentation

For professional pharmaceutical sourcing, documentation is an essential part of material selection. Depending on availability and applicable requirements, documentation may include:

• Certificate of Analysis
• Batch identification
• Assay information
• Purity testing
• Appearance specification
• Analytical test results
• Storage recommendations
• Safety documentation
• Shipping documentation

Always compare supplier documentation with your internal quality requirements. Also, verify the legal status of importing and using erdafitinib in the destination country.

Worldwide Erdafitinib Powder Shipping

We support worldwide shipping for qualified customers, subject to destination-country regulations and applicable restrictions. Shipping requirements can differ significantly between countries.

Before ordering, customers should confirm import permissions, customs requirements, and pharmaceutical regulations in their destination market. Additionally, appropriate packaging and documentation should accompany each shipment.

Erdafitinib is associated with a prescription oncology medicine. The EMA states that treatment with Balversa should be initiated and supervised by a physician experienced in anticancer therapy.

Therefore, this product description is intended for professional pharmaceutical and research contexts. It should not be interpreted as medical advice or as instructions for personal treatment.

Order Erdafitinib Powder for Professional Use

Erdafitinib powder is a specialized pharmaceutical compound with applications in oncology research, API development, analytical testing, and formulation studies.

Its documented molecular formula is C25H30N6O2, with a molecular weight of 446.56 g/mol. Regulatory sources characterize the active substance as a crystalline yellow powder with limited aqueous solubility.

For professional sourcing, request the current batch documentation and verify your regulatory requirements before purchase. Product availability, packaging options, minimum order quantities, and shipping terms should also be confirmed before an order is finalized.

SEO keywords: erdafitinib powder, erdafitinib API, erdafitinib active pharmaceutical ingredient, buy erdafitinib powder, erdafitinib raw material, pharmaceutical erdafitinib, erdafitinib CAS, FGFR inhibitor, FGFR3 inhibitor, oncology research compound, erdafitinib supplier, erdafitinib manufacturer, erdafitinib wholesale, pharmaceutical research chemicals, erdafitinib worldwide shipping.